Published on 25/11/2020 5:48:19 PM | Source: Angel Broking Ltd

Quote On Drug launch by Yash Gupta, Angel Broking

Posted in Stock Market| #Expert Views #Angel Broking Ltd #Yash Gupta

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel 

Download Telegram App before Joining the Channel

Below is the Quote On Drug launch by Mr. Yash Gupta- Equity Research Associate, Angel Broking Ltd

“Lupin limited up by 1% at 902 on positive news of the launch of Tacrolimus Capsules. Lupin Limited announced the launch of Tacrolimus Capsules USP after Lupin’s alliance partner Concord Biotech Limited received an approval for its ANDA from the United States Food and Drug Administration (U.S. FDA). Tacrolimus Capsules USP, 0.5 mg, 1 mg, and 5 mg, are the generic equivalent of Prograf® Capsules, of Astellas Pharma US, Inc. and are indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic kidney transplant, liver transplant, and heart transplant, and in pediatric patients receiving allogeneic liver transplants, in combination with other immunosuppressants. Tacrolimus Capsules USP had an annual sale of approximately USD 303 million in the U.S. as per IQVIA MAT September 2020 data.”


Above views are of the author and not of the website kindly read disclaimer